Skip to Main Content

Paper Details

Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
Acta Neuropathol
2
2023
Author NameAffiliation
Adam L BoxerUniversity of California San Francisco
William W SeeleyUniversity of California San Francisco
  • 1 - 2

Datasets

Release 1.2